Growth Mixture Modeling (Gmm) to Determine Treatment Effects of Canagliflozin Versus Sitagliptin on Weight-Related Quality of Life (Wrqol) in Subjects with Type 2 Diabetes Mellitus (T2Dm)
Citation
Stull, D., Houghton, K., & Traina, SB. (2013). Growth Mixture Modeling (Gmm) to Determine Treatment Effects of Canagliflozin Versus Sitagliptin on Weight-Related Quality of Life (Wrqol) in Subjects with Type 2 Diabetes Mellitus (T2Dm). Value in Health, 16(7), A447-A447.